ASTRAZENECA PHARMA IND LT (ASTRAZEN)

NSE: ₹8,514.50
BSE: ₹8,497.05
Stock Performance
Corporate Announcements
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 – Resignation Of Senior Management Personnels

Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.

2026-06-12 12:19:34
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Please find the enclosed intimation of the Company as per the captioned subject for review.

2026-06-11 10:37:21
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

2026-06-04 15:39:38
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

2026-06-03 21:03:56
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 – Resignation Of Senior Management Personnel

Please find the enclosed letter of the Company in relation to the captioned subject for your reference.

2026-06-01 11:32:56
Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find the enclosed report of the Company as per the captioned subject for your reference.

2026-05-29 20:08:57
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

2026-05-26 19:49:21
Outcome Of The Board Meeting Held On Tuesday, May 26, 2026

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

2026-05-26 19:16:28
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Please find the enclosed intimation of the Company as per the captioned subject for reference.

2026-05-21 13:26:04
Determination Of Materiality – Details Of Key Managerial Personnel

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

2026-05-20 20:27:01

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 295.47 311.07 305.79 383.20 387.52 408.00 440.29 480.48 526.31 559.09 611.57 578.61
YOY Revenue Growth % 27.17% 31.74% 22.41% 34.6% 31.16% 31.16% 43.98% 25.39% 35.81% 37.03% 38.9% 20.42%
Other Income 8.10 8.37 9.66 8.66 8.35 8.15 7.98 16.15 11.24 6.17 5.13 5.95
Total Income 303.57 319.44 315.45 391.86 395.87 416.15 448.27 496.63 537.55 565.26 616.70 584.56
Total Expenses + 232.17 262.49 295.05 337.51 353.46 365.12 372.70 412.48 462.49 487.15 571.64 525.34
Cost of Materials Consumed 19.08 38.80 37.52 33.62 45.85 77.15 69.88 94.25 9.49 0.00 0.00 0.00
Employee Benefit Expense 54.97 65.27 63.23 57.98 60.96 68.04 62.37 66.07 64.45 60.45 93.78 45.70
Other Expenses 62.66 70.92 79.21 62.28 58.04 61.48 53.90 68.43 85.34 98.97 106.57 77.75
Operating Profit 63.29 48.59 10.74 45.69 34.06 42.88 67.59 68.00 63.82 71.94 39.93 53.27
OPM % 21.4% 15.6% 3.5% 11.9% 8.8% 10.5% 15.4% 14.2% 12.1% 12.9% 6.5% 9.2%
Profit Before Tax + 71.40 73.38 20.40 54.35 -15.16 51.03 42.02 78.47 74.70 72.82 46.54 58.14
Tax Expense 17.54 21.01 4.60 14.88 -3.37 12.60 11.17 20.22 18.87 18.60 13.95 13.26
Tax % 24.6% 28.6% 22.5% 27.4% - 24.7% 26.6% 25.8% 25.3% 25.5% 30% 22.8%
Profit After Tax 53.86 52.37 15.80 39.48 -11.79 38.43 30.85 58.25 55.83 54.22 32.59 44.88
EPS (Basic) 21.54 20.95 6.32 15.79 -4.72 15.37 12.34 23.30 22.33 21.69 13.04 17.95

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56 831.81
YOY Revenue Growth % 32.59% 32.48% 29.17% 24.5% -0.98% -2.19% -
Other Income 28.49 40.63 34.80 26.10 14.76 12.84 12.99
Total Income 2,304.07 1,756.92 1,330.33 1,029.07 820.36 826.41 844.80
Total Expenses + 2,046.62 1,503.77 1,127.22 854.74 737.32 699.31 476.09
Cost of Materials Consumed 9.49 287.13 129.02 84.38 89.61 97.26 70.21
Employee Benefit Expense 264.38 257.44 241.45 259.10 230.21 219.54 216.70
Other Expenses 368.63 241.87 275.07 218.77 177.26 163.60 189.18
Operating Profit 228.96 212.52 168.31 148.23 68.28 114.25 355.72
OPM % 10.1% 12.4% 13% 14.8% 8.5% 14% 42.8%
Profit Before Exceptional 257.45 253.15 203.11 174.33 83.04 127.09 113.96
Exceptional Items -5.25 -96.79 16.43 -40.23 0.00 0.00 0.00
Profit Before Tax + 252.20 156.36 219.54 134.10 83.04 127.09 113.96
Tax Expense 64.68 40.62 58.03 34.81 21.44 33.79 41.75
Tax % 25.6% 26% 26.4% 26% 25.8% 26.6% 36.6%
Profit After Tax 187.52 115.74 161.51 99.29 61.59 93.30 72.21
EPS (Basic) 75.01 46.30 64.60 39.72 24.64 37.32 28.88

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 249.17 175.77 145.32 97.83 99.32 105.85 0.00
Property, Plant & Equipment 117.47 63.58 60.37 68.86 74.50 80.96 0.00
Capital Work in Progress 0.00 0.00 0.27 1.33 2.20 4.02 0.00
Non-Current Investments 0.00 0.00 52.63 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 2.11 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.66 0.00 0.00 0.00 0.00 0.00
Current Assets + 1,732.19 1,342.35 932.71 887.06 757.23 668.86 0.00
Inventories 1,027.33 548.50 227.88 190.21 140.22 159.80 0.00
Trade Receivables 213.68 184.88 153.13 107.52 85.89 85.19 0.00
Cash and Cash Equivalents 447.72 536.14 505.57 500.34 448.42 352.34 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 872.79 770.35 711.92 588.69 511.39 456.17 0.00
Equity Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 0.00
Other Equity 867.79 765.35 706.92 583.69 506.39 451.17 0.00
Non-Current Liabilities 134.50 44.77 8.99 12.26 12.52 15.04 0.00
Current Liabilities 981.81 703.00 357.12 383.94 332.65 303.50 0.00
Total Liabilities 1,116.31 747.77 366.11 396.20 345.16 318.54 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -15.14 65.36 92.53 58.30 100.79 104.78 0.00
Cash from Investing Activities 18.69 30.80 21.74 18.11 4.74 173.03 0.00
Cash from Financing Activities -91.97 -65.59 -44.37 -24.48 -9.46 -8.97 0.00
Net Increase/Decrease in Cash -88.42 30.57 69.90 51.92 96.08 268.84 0.00